14 Dec 2001
HEALTHCARE: Pharma giant Roche has handed Counsel a six-figure PR
brief for market-leading indigestion treatment Rennie. The Huntsworth
Group firm was appointed after a two-way pitch against incumbent Weber
Shandwick Worldwide.
14 Dec 2001
Specialist pharma products firm The Martindale Group has hired Fuel
as its communications adviser.
Fuel's one-year brief is to raise Martindale's corporate and product
profile within the trade. Fuel owner and manager Gillian Waddell will
handle the account.
Martindale is the UK pharmaceutical...
14 Dec 2001
| by Edited by JOE LEPPER
Plans to make more drugs available to consumers have prompted the
over-the-counter industry's trade body to revamp its PR.
The Government wants to increase the number of OTC drugs available, with
the morning-after pill being this year's most controversial switch from
prescription-only....
14 Dec 2001
DUBLIN: IVAX Pharmaceuticals has hired Plunkett Communications to
handle PR across Ireland. Account director Ciara Sweeney leads the
brief. Other recent client wins include the Nuremore Hotel & Country
Club and the New House Interiors & Garden Show, which is co-ordinated by
Expo Exhibitions....
07 Dec 2001
Two websites launch this week to provide healthcare PROs with
access to information and research data.
Condom manufacturer Durex has launched an online sexual health resource,
while Health Media Group has relaunched health-news.co.uk, which
provides education and information services, in...
30 Nov 2001
| by HOLLY WILLIAMS
Pro-life groups ramped up their PR efforts this week to make plain
their condemnation of human embryo research following the creation of
the first embryonic human clone in the US.
Political campaigners The ProLife Alliance and charity LIFE have been
quick to put emergency media relations...
30 Nov 2001
| by ALLEN HOUSTON
WARREN, NJ: Makovsky & Company will spearhead a campaign by
pharmaceutical company Celgene to expand its controversial drug
Thalidomide to European and Australian markets.
Once banned in the US, the drug was given limited FDA approval in 1998
as a treatment for leprosy. More recently, however,...
30 Nov 2001
| by ED SHELTON
The news this week that the NHS organisation responsible for
communicating best practice procedure has itself sought PR help might
alarm some. But with the outgoing president of the General Medical
Council Sir Donald Irvine last week saying that patient demands are
increasingly as exacting as...
23 Nov 2001
| by PETER SIMPSON
GENEVA: The International Federation of Pharmaceutical
Manufacturers has taken on APCO Worldwide to handle communications
surrounding the global debate on medicine trade policy.
APCO UK will oversee reputation management on the pan-European brief,
which is to be co-ordinated by APCO's dedicated...
16 Nov 2001
NEW YORK: Ketchum has won a PR brief for Novartis'
yet-to-be-branded arthritis treatment. The agency beat Hill & Knowlton
and Chamberlain Communications Group for the account to handle all
communications in the US for the COX189 through the drug's launch. The
drug is expected to become available...